Over 201.6 mn unutilised COVID-19 vaccine doses available, says Centre

More than 201.6 mn unutilised COVID-19 vaccine doses are still available with States and Union Territories (UTs) to be administered, informed the Ministry of Health and Family Welfare on Thursday

vaccine
A health worker inoculates a woman with a Covid-19 booster dose at a private hospital in New Delhi | Photo: PTI
ANI General News
2 min read Last Updated : Apr 21 2022 | 11:08 AM IST

More than 20.16 crore balance and unutilized COVID-19 vaccine doses are still available with States and Union Territories (UTs) to be administered, informed the Ministry of Health and Family Welfare in its official statement on Thursday.

"More than 192.27 crore (1,92,27,23,625) vaccine doses have been provided to States/UTs so far through the Government of India (free of cost channel) and through direct state procurement category," said the ministry.

"More than 20.16 crore (20,16,91,220) balance and unutilized COVID-19 Vaccine doses are still available with the States/UTs to be administered," it added.

The Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country, said the ministry.

As per the ministry, the nationwide COVID-19 vaccination started on January 16, 2021. The new phase of universalization of COVID-19 vaccination commenced on June 21, 2021.

As part of the nationwide vaccination drive, the Government of India has been supporting the States and UTs by providing them with COVID Vaccines free of cost.

In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply (free of cost) 75 per cent of the vaccines being produced by the vaccine manufacturers in the country to States and UTs.

The vaccination drive has been ramped up through the availability of more vaccines, and advanced visibility of vaccines available to the states and UTs for enabling better planning by them and streamlining the vaccine supply chain.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineCorona Remedies

First Published: Apr 21 2022 | 11:08 AM IST

Next Story